• Clario accelerates your clinical trial from initiation to implementation. LEARN MORE →

Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario
  • Solutions
    • eCOA Digital Solutions
      • eCOA Digital Solutions
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Cardiac Safety
      • Cardiac Safety
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • FlexImaging
      • Image Redact AI
      • Image Repository
      • Imaging Platform
      • Image Workflow
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion
      • Precision Motion: Scientific Consulting Services
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Cough and Lung Sounds
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Clinical Trial Management
      • Electronic Data Capture (EDC)
      • Eligibility Solution
      • Payments
      • Randomization and trial supply management
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials
      • Decentralized Trials
      • eConsent
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Respiratory Solutions
  • Resources
    • Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Values & Culture
    • Security Governance
    • Corporate & Social Responsibility
    • Leadership
    • Scientific Expertise
    • Strategic Partnerships
    • Legal & Privacy
  • Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home About Newsroom Clario simplifies access to its clinical trial platform with launch of new Federated Identity Management System to increase security and improve user experience

Clario simplifies access to its clinical trial platform with launch of new Federated Identity Management System to increase security and improve user experience

  • Data security is one of the highest priorities when managing clinical trials. Clario’s new Federated Identity Management (FIM) System means clients now have the option to use their own trusted login credentials to access Clario’s services
  • FIM enables our customers to enforce their own security policies across Clario’s Clinical Platform, providing greater control over access to data, and compliance with data protection regulations, such as GDPR and HIPAA
  • FIM also simplifies everyday operations performed by site users by reducing the number of credentials they must maintain, allowing them to access information seamlessly without compromising security

PHILADELPHIA, PA – March 28, 2023 – Clario, a leading healthcare research and technology company that generates the richest clinical evidence for the clinical trials industry, today announced the launch of its Federated Identity Management (FIM) System, which has been developed to provide a more user-friendly and secure authentication method for its already best-in-class clinical trial platform. FIM is a way of managing access to online resources and services by allowing users to use the same login credentials across different systems and organizations. With FIM, users no longer need to remember multiple usernames and passwords for different websites or applications, making it easier and more convenient for them to access the resources they need while improving security by reducing the need for multiple accounts and passwords.

“Keeping data secure during clinical trials is essential to protect patient privacy and ensure compliance with data protection regulations, such as GDPR and HIPAA,” said Jay Ferro, Clario’s Chief Technology, Information & Product Officer. “Federated Identity Management ensures clinical trial data entrusted to Clario is secured through state-of-the-art industry standards like Multi-Factor Authentication, allowing ease-of-use and compliance with regulations while also being seamless, secure and easy to use for our clients and clinical trial staff.”

Through direct integration of external Identity Providers into the Clario Federated Identity Management System, clients can use their trusted login credentials to access Clario’s service offerings. This not only simplifies the access of information for users but also allows clients to have full autonomy over the security of their account credentials. In addition, Clario has extended its Single Sign-On solution with Multi-Factor Authentication to protect users’ accounts against outside threats, creating a stand-out solution that is both highly secure and easy to use.

In the name of increased security, many people collecting data for clinical trials are being asked to register with more and more applications, which means that they accumulate many apps, links, usernames, and passwords, which is burdensome to manage and can be less secure. Introducing Federated Identity Management is an essential step in simplifying everyday operations by reducing the number of credentials users must maintain, allowing them to seamlessly access information at enabled vendor sites without needing further credentials. This means that those involved in clinical trials will have improved data security while also improving user experience and reducing complexity.


About Clario

Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario’s global team of science, technology and operational experts have helped deliver over 24,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years. For more information, visit Clario.com or follow us on LinkedIn and Twitter.

Back to news
Share
Twitter Facebook LinkedIn

Latest News

See all news

Clario Announces Strategic Partnership Supporting CancerX and White House Cancer Moonshot

June 2, 2023 Read more

Transforming clinical trial endpoint analysis: Clario implements over 30 AI solutions to deliver faster and accurate results 

May 23, 2023 Read more

Clario celebrates over 50 years of innovation and expertise in clinical trials for Clinical Trials Day 

May 19, 2023 Read more
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • News
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below or send us an email.

Customer support

Questions regarding your clinical trial technology or need technical support? Our customer care teams are ready to help you.

Customer support

Media contact

If you would like to speak with one of our innovators or thought leaders, connect with our public relations team.

Email: [email protected]

Our Locations

View our locations

Thanks for your form. Our team will be in touch very soon.

  • © 2023 Clario

    • Legal and Privacy Terms
    • Security Governance
    • Cookie Policy
    • Impressum

Please enter your business email before proceeding to xTalks to complete registration.

×